The Centers for Medicare & Medicaid Services unveiled a new program for alternative payment model participants that would allow clinicians to use products containing CBD as part of patient care plans. In response, the Food and Drug Administration vowed not to further restrict the sale of oral hemp products.
While much of the attention paid to AI in healthcare has focused on applications to improve care and the administration thereof, industry players have quietly begun tapping the technology to boost sales of their healthcare wares.
Kaiser Permanente, a large health system based in California, will be forced to follow the same disclosure laws as other healthcare payers and providers in the state thanks to a new law signed by Gov. Gavin Newsom.
Amid an outbreak of hundreds of lung disease illnesses and two deaths related to e-cigarette use, investigators from the New York State Department of Health may have finally determined what is making people so sick across the country. Vitamin E acetate has become the focus of the Department after it was found in nearly all cannabis-containing samples analyzed by its investigation.
There’s still a long way to go with both research into Alzheimer’s disease and AI tools to help detect it, but deep-learning approaches continue to show promise for classifying the condition on images of the brain.
